ALAFURO ORUENE: Open Payments
NPI 1649230491 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$810 in 35 payments from 10 companies in 2025. Trend: 2023 $289 · 2024 $561 · 2025 $810
Food & beverage: $810
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 14 | $316 |
| Forte Bio-Pharma LLC | 9 | $253 |
| PFIZER INC. | 4 | $103 |
| ABBVIE INC. | 2 | $40 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Corcept Therapeutics | 1 | $19 |
| Novo Nordisk Inc | 1 | $18 |
| Nalu Medical, Inc. | 1 | $18 |
| Dexcom, Inc. | 1 | $17 |
| Electronic Waveform Lab, Inc. | 1 | $3 |
Products named: RELISTOR, PROLATE, NURTEC ODT, QULIPTA, Kerendia, Korlym, Nalu Neurostimulation System, Dexcom G6 Transmitter.
Industry payments across NV — which companies pay providers there.
